Probably in couple of weeks in pre-clinical , double blind study they can prove if with Leronlimab disease is not as severe with less mortality...

I will not be surprise if Dr Patterson will be doing that already..and then FDA can give emergency approval just for those patients..

Yes Craig , this is a fact...


All IMO...